Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sofie‐Katrin Kadel
Observed names:
S Kadel,
S. Kadel,
S.-K. Kadel,
S.K. Kadel,
SK Kadel,
Sofie Kadel,
Sofie-Katrin Kadel
show all 7
Institutions:
University of Würzburg,
Helmholtz Centre for Infection Research,
Helmholtz Institute for RNA-based Infection Research,
Universitätsklinikum Würzburg
Observed institutions:
University of Würzburg,
Medizinische Hochschule Hannover,
Helmholtz Centre for Infection Research,
Helmholtz Institute for RNA-based Infection Research,
Universitätsklinikum Würzburg
ORCID:
0009-0003-8871-5261
Observed ORCID:
0009-0003-8871-5261
OpenAlex ID:
A5084692128
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma
2024
·
Mara John
, Moutaz Helal
, et al.
·
Blood
·
67
RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia
2022
·
Sofia Gialesaki
, Daniela Bräuer-Hartmann
, et al.
·
Blood
·
45
PDF
Delayed Neurotoxicity after CAR-T in Multiple Myeloma: Results from a Global IMWG Registry
2024
·
Anupama Deepa Kumar
, Suheil Albert Atallah-Yunes
, et al.
·
Blood
·
23
PDF
Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma
2023
·
C Riedhammer
, J Düll
, et al.
·
Annals of Hematology
·
10
PDF
The Impact of Treatment-Free Intervals on T-Cell Exhaustion and Clonotypic Diversity in Myeloma Patients Treated with BCMA Bispecific Antibodies
2023
·
Florian Eisele
, Nazia Afrin
, et al.
·
Blood
·
10
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D
2026
·
C. Riedhammer
, M. Truger
, et al.
·
Leukemia
·
7
PDF
Changes in T‐cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T‐cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study
2024
·
Xiang Zhou
, Vivien Wagner
, et al.
·
British Journal of Haematology
·
5
Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion concept
2026
·
Anna Fleischer
, Magdalena Roll
, et al.
·
Supportive Care in Cancer
·
2
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy
2026
·
Sofie-Katrin Kadel
, Lukas Scheller
, et al.
·
Blood Cancer Discovery
·
2
Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR‐T therapy
2025
·
Lukas Scheller
, Xiang Zhou
, et al.
·
HemaSphere
·
2
The Role of Clonally Expanded CD8+ Non-CAR-T Cells in Neurocognitive and Hypokinetic Movement Disorder after BCMA-Targeting CAR-T Cell Therapy
2024
·
Sofie-Katrin Kadel
, Lukas Scheller
, et al.
·
Blood
·
2
PDF
RUNX1 isoform disequilibrium in the development of trisomy 21 associated myeloid leukemia
2022
·
Sofia Gialesaki
, Daniela Bräuer-Hartmann
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Increased teclistamab dosing interval improves T-cell diversity and reduces infection risk, while T-cell exhaustion remains minimal irrespective of schedule
2025
·
Nazia Afrin
, Florian Eisele
, et al.
·
Blood
·
1
PDF
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D
2025
·
Christine Riedhammer
, Marietta Truger
, et al.
·
Blood
·
1
PDF
Patient preferences for treatment‑free intervals in multiple myeloma: mixed‑methods insights on monitoring trade‑offs and supportive care improvements
2026
·
Anna Fleischer
, Mohammad Barakat
, et al.
·
Supportive Care in Cancer
PDF
Gustatory dysfunction under talquetamab therapy in multiple myeloma: a cross-sectional study of patient-reported course, nutritional changes, and quality of life
2026
·
Anna Fleischer
, Carolin Burger
, et al.
·
Supportive Care in Cancer
PDF
Data from Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy
2026
·
Sofie-Katrin Kadel
, Lukas Scheller
, et al.
Supplementary Figures S1-S8 from Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy
2026
·
Sofie-Katrin Kadel
, Lukas Scheller
, et al.
Table S1-S15 from Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy
2026
·
Sofie-Katrin Kadel
, Lukas Scheller
, et al.
B10 | Hepta-refractory Multiple Myeloma: Biology, Prognosis, and Treatment
2026
·
C. Riedhammer
, M. Truger
, et al.
·
Haematologica
PDF
P45 | Modeling Dormancy in Multiple Myeloma: Functional and Transcriptomic Characterization of Serum Starvation and Chemotherapy-induced States
2026
·
Z.S. Najafabadi
, N. Afrin
, et al.
·
Haematologica
PDF
O12.01 Increased teclistamab dosing interval improves clonotypic diversity and reduces infection risk in multiple myeloma
2026
·
N Afrin
, F Eisele
, et al.
·
Oral Presentations
PDF
Single-cell profiling reveals teclistamab-induced reshaping of nasopharyngeal immunity in multiple myeloma
2025
·
Sofie-Katrin Kadel
, Alexander Leipold
, et al.
·
Blood
Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and adverse outcome of CAR-T therapy
2025
·
Lukas Scheller
, Xiang Zhou
, et al.
·
Blood
Immuntherapien des multiplen Myeloms
2025
·
Sofie-Katrin Kadel
, Leo Rasche
·
Die Onkologie
Show more works
View as search
Works count:
30
Citation count:
179
H-index:
6
I10-index:
5
Year
Topic
Type
